Encompass Health Corp (EHC)
| Market Cap | 12.08B-2.2% |
| Revenue (ttm) | 6.21B |
| Net Income | 603.70M |
| EPS | 5.98 |
| Shares Out | 98.65M |
| PE Ratio | 20.48 |
| Forward PE | 18.34 |
| Dividend | $0.84(0.69%) |
| Ex-Dividend Date | Oct 1, 2026 |
| Volume | 875,238 |
| Open | 124.86 |
| Previous Close | 124.69 |
| Day's Range | 121.99 - 125.44 |
| 52-Week Range | 92.77 - 127.99 |
| Beta | 0.60 |
| Analysts | Strong Buy |
| Price Target | 148.17(+20.97%) |
| Earnings Date | Oct 28, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About EHC
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$EHC stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in EHC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by EHC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
EHC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
EHC Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Net operating revenues | $1.60B | 78.84% |
| Adjusted EBITDA | $348.00M | 17.18% |
| Supplies | $66.10M | 3.26% |
| Occupancy costs | $14.70M | 0.73% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New EHC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to EHC from public contracts
Source: USAspending.gov
EHC Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from EHC’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score